Entourage launches medical cannabis marketplace “Syndicate,” offering craft products from collective of micro producers
September 27, 2022 By Haley Nagasaki
(Globe Newswire) Toronto — Entourage Health Corp., a Canadian producer and distributor of award-winning cannabis products is pleased to announce the launch of Syndicate, a direct-to-patient medical cannabis marketplace showcasing a portfolio of premium craft cannabis products sourced both in-house and from third-party micro-cultivators and producers. The company is one of the first to launch a medical-marketplace collective of craft producers.
Syndicate complements the company’s popular medical platform Starseed Medicinal, which specializes as a medical cannabis provider to clients with insurance benefits coverage.
With Syndicate, patients without insurance coverage can access a comprehensive catalogue of cannabis products, formats, and brands at a competitive price point. A unique model that offers an assortment of products from various producers, including partnerships with Greenseal Cannabis, Sitka Micro, Premium 5 and QWest Cannabis; a collective of micro-cultivators looking to distribute small-batch brands into the medical channel.
“Launching Syndicate as a supplementary medical marketplace has been a long-time passion project for many of us at Entourage because it reinforces our commitment to providing optimal patient care with access to locally produced, quality cannabis products within a framework of affordability. Additionally, in supporting craft producers with a medical outlet to share their unique offerings with our patients, we are taking our medical business to the next level. Our Syndicate clients will have the same patient-centric services currently offered to our Starseed clients – all rooted in innovation, technology and education.” — Nikki Thomas, Marketing Director, Entourage
“The original purpose for launching our Company in 2013 harkens back to our deep-seeded belief that medical cannabis as a wellness option should be made available to all eligible Canadians and we are proud to be partnering with these micro-cultivators and licensed producers who share in this mission. With Syndicate, we are returning to our roots with access to medical cannabis at the heart of our purpose. We continue to advocate for cannabis medicine to be an insured benefit, but we know the reality is that not all our clients have access and this channel is dedicated to those patients.” — George Scorsis, CEO and Executive Chairman, Entourage
Print this page